These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32116676)

  • 21. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
    Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
    Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia.
    Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E
    Eur Psychiatry; 2015 Feb; 30(2):296-302. PubMed ID: 25284335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
    Vasudev K; Choi YH; Norman R; Kim RB; Schwarz UI
    Can J Psychiatry; 2017 Feb; 62(2):138-149. PubMed ID: 27681143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potential mechanism underlying atypical antipsychotics-induced lipid disturbances.
    Cai HL; Tan QY; Jiang P; Dang RL; Xue Y; Tang MM; Xu P; Deng Y; Li HD; Yao JK
    Transl Psychiatry; 2015 Oct; 5(10):e661. PubMed ID: 26485545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
    Reynolds GP; Templeman LA; Zhang ZJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants.
    Himmerich H; Minkwitz J; Kirkby KC
    Endocr Metab Immune Disord Drug Targets; 2015; 15(4):252-60. PubMed ID: 26100432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia.
    Kim E; Park DW; Choi SH; Kim JJ; Cho HS
    J Clin Psychopharmacol; 2008 Apr; 28(2):138-46. PubMed ID: 18344723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.
    Perez-Iglesias R; Mata I; Amado JA; Berja A; Garcia-Unzueta MT; Martínez García O; Arranz MJ; Vazquez-Barquero JL; Crespo-Facorro B
    J Clin Psychopharmacol; 2010 Dec; 30(6):661-6. PubMed ID: 21105276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relationship Between Selected CNR1, MC4R, LEP, FTO and VDR Gene Polymorphisms and Several Basic Toxicological Parameters Among Persons Occupationally Exposed to Arsenic, Cadmium and Lead.
    Matys T; Szymańska-Chabowska A; Bogunia-Kubik K; Smyk B; Kamińska M; Mazur G; Poręba R; Gać P
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32272684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.
    Liou YJ; Bai YM; Lin E; Chen JY; Chen TT; Hong CJ; Tsai SJ
    Pharmacogenomics J; 2012 Feb; 12(1):54-61. PubMed ID: 20877301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacogenetics of antipsychotic-induced adverse events.
    Müller DJ; Chowdhury NI; Zai CC
    Curr Opin Psychiatry; 2013 Mar; 26(2):144-50. PubMed ID: 23370274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
    Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
    Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
    J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association of Polymorphisms in Leptin/Leptin Receptor Genes and Ghrelin/Ghrelin Receptor Genes With Overweight/Obesity and the Related Metabolic Disturbances: A Review.
    Ghalandari H; Hosseini-Esfahani F; Mirmiran P
    Int J Endocrinol Metab; 2015 Jul; 13(3):e19073. PubMed ID: 26425125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis.
    Sicard MN; Zai CC; Tiwari AK; Souza RP; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ
    Pharmacogenomics; 2010 Nov; 11(11):1561-71. PubMed ID: 21121776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.